116
|
349
|
8u8kA |
Co-crystal structure of phosphorylated erk2 in complex with erk1/2 inhibitor #8 |
119
|
352
|
8u8jA |
Co-crystal structure of phosphorylated erk2 in complex with erk1/2 inhibitor #16 |
103
|
350
|
7w5oA |
Crystal structure of erk2 with an allosteric inhibitor |
109
|
362
|
7opmA |
Phosphorylated erk2 in complex with orf45 |
3
|
18
|
7opmB |
Phosphorylated erk2 in complex with orf45 |
105
|
347
|
7e73A |
Crystal structure of human erk2 mutant (y36h) |
109
|
349
|
7e75A |
Crystal structure of human erk2 mutant (g37c) |
109
|
346
|
7ugbA |
Crystal structure of rat erk2 complexed with docking peptide from isg20 |
1
|
14
|
7ugbI |
Crystal structure of rat erk2 complexed with docking peptide from isg20 |
112
|
351
|
7xc1A |
Crystal structure of erk2 with an allosteric inhibitor 3 |
113
|
350
|
7x4uA |
Crystal structure of erk2 with an allosteric inhibitor 2 |
107
|
346
|
8aoeA |
Specific covalent inhibitor(15) of erk2 |
112
|
346
|
8aoaA |
Covalent and non-covalent inhibitor of erk2 (two sites) |
106
|
346
|
8ao6A |
Electrophilic inhibitor (7) of erk2 |
114
|
346
|
8aoiA |
Specific covalent inhibitor(19) of erk2 |
105
|
346
|
8aogA |
Non-specific covalent inhibitor(17) of erk2 |
113
|
347
|
8aojA |
Specific covalent inhibitor of erk2 |
107
|
346
|
8ao9A |
Specific covalent inhibitor(10) of erk2 |
107
|
347
|
8ao4A |
Specific covalent inhibitor (5) of erk2 |
110
|
342
|
8ao5A |
Specific covalent inhibitor (6) of erk2 |
110
|
346
|
8aodA |
Specific covalent inhibitor(14) of erk2 |
107
|
346
|
8aohA |
Specific covalent inhibitor(18) of erk2 |
108
|
346
|
8ao8A |
Specific covalent inhibitor(9) of erk2 |
110
|
339
|
8aobA |
Specific covalent inhibitor(12) of erk2 |
109
|
347
|
8ao3A |
Specific covalent inhibitor of erk2 |
106
|
345
|
8ao2A |
Specific covalent inhibitor (3) of erk2 |
112
|
346
|
8aocA |
Specific covalent inhibitor of erk2 |
114
|
346
|
8ao7A |
Specific covalent inhibitor (8) of erk2 |
106
|
346
|
8aofA |
Specific covalent inhibitor(16) of erk2 |
110
|
346
|
7nqqA |
Discovery of astx029, a clinical candidate which modulates the phosphorylation and catalytic activity of erk1/2 |
101
|
345
|
7nr9A |
Discovery of astx029, a clinical candidate which modulates the phosphorylation and catalytic activity of erk1/2 |
114
|
346
|
7nqwA |
Discovery of astx029, a clinical candidate which modulates the phosphorylation and catalytic activity of erk1/2 |
113
|
346
|
7nr8A |
Discovery of astx029, a clinical candidate which modulates the phosphorylation and catalytic activity of erk1/2 |
109
|
347
|
7nr5A |
Discovery of astx029, a clinical candidate which modulates the phosphorylation and catalytic activity of erk1/2 |
109
|
346
|
7nr3A |
Discovery of astx029, a clinical candidate which modulates the phosphorylation and catalytic activity of erk1/2 |
111
|
347
|
7auvA |
The structure of erk2 in complex with dual inhibitor astx029 |
111
|
351
|
6rfpA |
Erk2 map kinase with mutations at helix-g |
107
|
339
|
6rq4A |
Inhibitor of erk2 |
112
|
339
|
6slgA |
Human erk2 with erk1/2 inhibitor, azd0364. |
110
|
349
|
6opgA |
Phosphorylated erk2 with amp-pnp |
89
|
347
|
6opiA |
Phosphorylated erk2 with sch-cpd336 |
115
|
347
|
6nbsA |
Wt erk2 with compound 2507-8 |
113
|
346
|
6opkA |
Phosphorylated erk2 with vertex-11e |
113
|
348
|
6ophA |
Phosphorylated erk2 with gdc-0994 |
109
|
348
|
6ot6A |
Rat erk2 d319n |
88
|
350
|
6otsA |
Rat erk2 e320k |
100
|
347
|
6dmgA |
A multiconformer ligand model of ek6 bound to erk2 |
97
|
345
|
6d5yA |
Crystal structure of erk2 g169d mutant |
116
|
346
|
6flvA |
Crystal structure of erk2 in complex with an adenosine derivative |
115
|
346
|
6fmaA |
Crystal structure of erk2 in complex with an adenosine derivative |